Astrazeneca PLC (AZN)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS

1 FRANCIS CRICK AVENUE CAMBRIDGE, UNITED KINGDOM CB2 0AA

AstraZeneca is a prescription-based biopharmaceutical company. Co. discovers, develops and commercializes prescription medicines for six areas of healthcare: Cardiovascular, Gastrointestinal, Infection, Neuroscience, Oncology and Respiratory and Inflammation. Co. maintains a range of products which includes a number of key products such as: Arimidex (for breast cancer), Crestor (for managing cholesterol levels), Nexium (for acid reflux), Seroquel (for schizophrenia and bipolar disorder), Synagis (for RSV, a respiratory infection in infants) and Symbicort (for asthma and chronic obstructive pulmonary disease). Co. is active in over 100 countries.

Data based on most recent fiscal year report
Market Cap44.342 Billion Shares Outstanding1.259 Billion Avg Volume7.03 Million
1-Yr BETA vs S&P TR0.422 Current Ratio1.49 Quick Ratio1.37
View SEC Filings from AZN instead.
Q3 2019 All Institutions Hedge Funds 1
To trade AZN now:
Filers who had this stock in their top 10: 6 0 (0.0%)
13F Filers holding this stock: 526 54 (5.64%)
Aggregate 13F shares on 09/30/2019: 453.824 Million 30.932 Million
Aggregate 13F shares on 06/30/2019: 459.737 Million 33.823 Million
Percent change: -1.29% -8.55%
Funds creating new positions: 59 10
Funds Adding to an existing position: 176 17
Funds closing out their position: 45 6
Funds reducing their position: 177 15
1 hedge funds as identified by whalewisdom.com through public filings.

Funds Holding AZN (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5
No current insider transactions
Click here to report any possible errors with this stock listing.

Elevate your investments